Treatment strategies for progressive immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome: case series
Jack J. Scala,
Michael J. Eckrich,
Keagan Lipak,
Bonnie Yates,
Constance Yuan,
Hao-Wei Wang,
Saurabh Dahiya,
Jan-Inge Henter,
Jeffrey S. Huo,
Matthew J. Frank,
Nirali N. Shah
Affiliations
Jack J. Scala
Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford Cancer Institute, Stanford University, School of Medicine, Stanford, CA
Michael J. Eckrich
Pediatric Stem Cell Transplant and Cellular Therapy, Atrium Health Levine Children’s Hospital, Charlotte, NC
Keagan Lipak
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Bonnie Yates
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Constance Yuan
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD
Hao-Wei Wang
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD
Saurabh Dahiya
Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford Cancer Institute, Stanford University, School of Medicine, Stanford, CA
Jan-Inge Henter
Division of Pediatric Oncology and Surgery, Department of Women’s and Children’s Health, Karolinska Institute, and Department of Paediatric Oncology, Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden
Jeffrey S. Huo
Pediatric Stem Cell Transplant and Cellular Therapy, Atrium Health Levine Children’s Hospital, Charlotte, NC
Matthew J. Frank
Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford Cancer Institute, Stanford University, School of Medicine, Stanford, CA
Nirali N. Shah
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
